Rituximab in ANCA-Associated Vasculitis

被引：41
|
作者：
Hassan, Romina I. [1 ]
Gaffo, Angelo L. [2 ,3 ]
机构：
[1] JM Ramos Mejia Hosp, Div Rheumatol, 609 Gen Urquiza St, RA-1221 Buenos Aires, DF, Argentina
[2] Birmingham VA Med Ctr, 700 19th St S, Birmingham, AL 35233 USA
[3] Univ Alabama Birmingham, Div Rheumatol & Clin Immunol, 1825 Univ Blvd,SHEL 306, Birmingham, AL 35294 USA
来源：
CURRENT RHEUMATOLOGY REPORTS | 2017年 / 19卷 / 02期
关键词：
Rituximab; Vasculitis; ANCA; Granulomatosis with polyangiitis (GPA); Microscopic polyangiitis (MPA); Eosinophilicgranulomatosiswith polyangiitis (EGPA); WEGENERS-GRANULOMATOSIS; RANDOMIZED-TRIAL; PLASMA-EXCHANGE; CYCLOPHOSPHAMIDE; INDUCTION; REMISSION; THERAPY; MAINTENANCE; MANAGEMENT; RELAPSES;
D O I：
10.1007/s11926-017-0632-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Purpose of Review The purpose of this review is to describe the efficacy and safety of rituximab (RTX) as a remission induction and maintenance therapy in ANCA-associated vasculitis (AAV). Recent Findings A PubMed search was carried out to track down articles published between February 2006 and February 2016. Randomized controlled trials (RCTs) that encompassed patients with AAV were included. The American College of Rheumatology (ACR) and the European League against Rheumatism (EULAR) 2014-2015 online abstracts were also reviewed whether they were RTCs or not. Ten PubMed RCTs were analyzed along with eight ACR and four EULAR abstracts. RTX was not inferior to cyclophosphamide (CYC) for remission induction in AAV; it was superior to CYC in patients with relapsing disease and superior for remission maintenance in comparison with azathioprine (AZA). Summary Rituximab is a therapeutic option to induce and maintain remission in patients with AAV.
引用
收藏
页数：8
相关论文
共 50 条
  • [31] Rituximab and B-Cell Return in ANCA-Associated Vasculitis
    Wilde, Benjamin
    Witzke, Oliver
    Tervaert, Jan Willem Cohen
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2014, 63 (06) : 1066 - 1066
  • [32] Rituximab Versus Cyclophosphamide for ANCA-Associated Vasculitis with Renal Involvement
    Geetha, Duvuru
    Specks, Ulrich
    Stone, John H.
    Merkel, Peter A.
    Seo, Philip
    Spiera, Robert
    Langford, Carol A.
    Hoffman, Gary S.
    Kallenberg, Cees G. M.
    St Clair, E. William
    Fessler, Barri J.
    Ding, Linna
    Tchao, Nadia K.
    Ikle, David
    Jepson, Brett
    Brunetta, Paul
    Fervenza, Fernando C.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 26 (04): : 976 - 985
  • [33] Rituximab versus azathioprine for maintenance therapy in ANCA-associated vasculitis
    Clark, Anna
    LANCET RHEUMATOLOGY, 2020, 2 (01): : E12 - E12
  • [34] Successful treatment of ANCA-associated vasculitis and CNS involvement with rituximab
    Zeglam, S.
    Werthmann, M.
    Scheicht, D.
    Bansmann, P.
    Strunk, J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 145 - 145
  • [35] Pharmacokinetics of Rituximab and Clinical Outcomes in Patients with ANCA-Associated Vasculitis
    Cornec, Divi
    Kabat, Brian
    Mills, John
    Cheu, Melissa
    Hummel, Amber
    Schroeder, Darrell
    Cascino, Matthew
    Brunetta, Paul
    Murray, David
    Snyder, Melissa
    Fervenza, Fernando
    Hoffman, Gary S.
    Kallenberg, Cees G. M.
    Langford, Carol A.
    Merkel, Peter A.
    Monach, Paul A.
    Seo, Philip
    Spiera, Robert F.
    St Clair, E. William
    Stone, John H.
    Barnidge, David
    Specks, Ulrich
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [36] Effect of rituximab on malignancy risk in patients with ANCA-associated vasculitis
    van Daalen, Emma E.
    Rizzo, Raffaella
    Kronbichler, Andreas
    Wolterbeek, Ron
    Bruijn, Jan A.
    Jayne, David R.
    Bajema, Ingeborg M.
    Rahmattulla, Chinar
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (06) : 1064 - 1069
  • [37] Rituximab for remission induction in elderly patients with ANCA-associated vasculitis
    Timlin, H.
    Lee, S. M.
    Manno, R. L.
    Seo, P.
    Geetha, Duvura
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 45 (01) : 67 - 69
  • [38] SEVERE INFECTIONS IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS TREATED WITH RITUXIMAB
    Segelmark, Leo
    Felipe Flores-Suarez, Luis
    Rathmann, Jens
    Mohammad, Aladdin
    RHEUMATOLOGY, 2019, 58
  • [39] Acquired hemophilia in association with ANCA-associated vasculitis: Response to rituximab
    Clatworthy, MR
    Jayne, DRW
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (04) : 680 - 682
  • [40] Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis.
    Jones, Rachel B.
    Tervaert, Jan Willem Cohen
    Hauser, Thomas
    Luqmani, Raashid
    Morgan, Matthew D.
    Peh, Chen Au
    Savage, Caroline O.
    Segelmark, Marten
    Tesar, Vladimir
    van Paassen, Pieter
    Walsh, Dorothy
    Walsh, Michael
    Westman, Kerstin
    Jayne, David R. W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (03): : 211 - 220
12345